In the News
Outsourcing-Pharma (April 2017)
PPD valued at more than $9bn as investors recapitalize
Outsourcing-Pharma provides insight into PPD's recapitalization.
FierceBiotech (April 2017)
Singapore, UAE government funds’ new investments put PPD at $9B
PPD’s recapitalization covered in FierceBiotech.
FierceBiotech (March 2017)
PPD builds clinical research associates apprentice program, targets military veterans
FierceBiotech reports on PPD’s new, industry-first CRA apprentice program that focuses on military veterans.
Regulatory Rapporteur (February 2017)
An analysis of specific Phase I safety issues
Kirsten Messmer co-authored this article that focuses on the importance of maximizing safety in clinical trials.
BioPharm International (February 2017)
Mass Spectrometry Measures Up to Analytical Challenges
Jie Ding discusses the importance of mass spectrometry in assigning the primary structure of biologic drugs.
CenterWatch (February 2017)
The need for—and barriers to—adopting eSource
John Manns discusses the use of electronic approaches at clinical trial sites.
FierceBiotech (February 2017)
PPD in nephrology collab with field expert Frenova
FierceBiotech reports on PPD’s nephrology collaboration with Frenova.
Outsourcing-Pharma (February 2017)
PPD combines rare disease and pediatrics in new ‘Center of Excellence’
Outsourcing-Pharma reports on PPD’s new center of excellence
FierceBiotech (February 2017)
PPD Establishes New Center for Rare Disease and Pediatrics
FierceBiotech reports on PPD’s new center of excellence.